| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 | Jan'18 | Oct'17 | Jul'17 | Apr'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||
Net loss | |||||||||||
-83,394 | -78,825 | -77,812 | -75,544 | -72,741 | -59,603 | -52,744 | -49,040 | -39,377 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation, amortization and accretion | |||||||||||
11,866 | 9,999 | 8,897 | 8,783 | 8,228 | 8,162 | 7,857 | 7,076 | 6,550 | 0 | 0 | 0 |
Stock-based compensation | |||||||||||
45,046 | 39,048 | 34,669 | 28,715 | 25,357 | 20,717 | 16,299 | 12,437 | 8,990 | 0 | 0 | 0 |
Provision for doubtful accounts | |||||||||||
3,887 | 2,660 | 3,689 | 4,098 | 3,949 | 5,060 | 5,473 | 4,156 | 3,306 | 0 | 0 | 0 |
Other | |||||||||||
- | 0 | 0 | 1,076 | - | 0 | 0 | 0 | - | - | - | - |
Amortization of deferred commissions | |||||||||||
9,500 | 9,200 | 8,956 | 8,483 | 8,000 | 0 | 0 | 0 | - | - | - | - |
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | |||||||||||
14,504 | 11,354 | 8,540 | 11,171 | 12,443 | 17,918 | 17,206 | 17,439 | 20,983 | 0 | 0 | 0 |
Prepaid expenses and other assets | |||||||||||
4,180 | 5,092 | 6,450 | 4,749 | 5,825 | 7,341 | 4,713 | 5,065 | 3,194 | 0 | 0 | 0 |
Deferred commissions | |||||||||||
11,411 | 11,427 | 11,494 | 12,606 | 13,556 | 0 | 0 | 0 | - | - | - | - |
Other assets | |||||||||||
- | - | 0 | 1,910 | - | - | 0 | 2,092 | - | 0 | 0 | 0 |
Accounts payable | |||||||||||
417 | -1,357 | -1,927 | -2,129 | -1,103 | -678 | -509 | -1,639 | -3,774 | 0 | 0 | 0 |
Accrued expenses and other liabilities | |||||||||||
627 | 8,506 | 2,117 | 4,829 | 5,856 | 4,972 | 5,140 | 5,391 | 4,387 | 0 | 0 | 0 |
Accrued employee liabilities | |||||||||||
1,590 | 2,711 | 1,648 | 8,858 | 4,902 | 9,958 | 8,003 | 5,787 | 6,371 | 0 | 0 | 0 |
Deferred revenue | |||||||||||
25,522 | 21,493 | 21,454 | 25,064 | 24,689 | 20,610 | 18,440 | 17,634 | 17,967 | 0 | 0 | 0 |
Other long-term liabilities | |||||||||||
- | - | 0 | -127 | - | - | 0 | 1,048 | - | 0 | 0 | 0 |
Net cash used in operating activities | |||||||||||
-3,590 | -14,588 | -24,467 | -17,917 | -23,581 | -23,491 | -21,980 | -28,244 | -24,776 | 0 | 0 | 0 |
Cash flows from investing activities: | |||||||||||
Purchases of property and equipment | |||||||||||
21,424 | 15,669 | 10,964 | 13,324 | 13,412 | 12,839 | 9,730 | 5,751 | 4,698 | 0 | 0 | 0 |
Purchases of short-term investments | |||||||||||
184,633 | 166,282 | 210,537 | 175,169 | 107,464 | 0 | 0 | 0 | - | - | - | - |
Sales of short-term investments | |||||||||||
3,497 | 3,496 | 3,496 | 3,496 | 0 | 0 | 0 | 0 | - | - | - | - |
Maturities of short-term investments | |||||||||||
172,800 | 155,800 | 90,400 | 55,900 | 0 | 0 | 0 | 0 | - | - | - | - |
Net cash used in investing activities | |||||||||||
-29,760 | -22,655 | -127,605 | -129,344 | -121,123 | -110,204 | -9,977 | -17,171 | -16,118 | 0 | 0 | 0 |
Cash flows from financing activities: | |||||||||||
Payments under capital leases | |||||||||||
0 | 2,287 | 3,159 | 3,387 | 3,623 | 1,991 | 1,642 | 1,782 | 2,081 | 0 | 0 | 0 |
Proceeds from issuance of common stock upon exercise of stock options | |||||||||||
12,079 | 11,436 | 11,864 | 10,578 | 11,481 | 10,848 | 8,934 | 8,897 | 4,453 | 0 | 0 | 0 |
Repurchases of unvested common stock | |||||||||||
119 | 78 | 59 | 52 | 18 | 0 | 0 | 0 | - | - | - | - |
Payments of offering costs | |||||||||||
0 | 0 | 127 | 2,507 | 4,399 | 0 | 0 | 0 | - | - | - | - |
Proceeds from initial public offering, net of underwriters’ discounts and commissions | |||||||||||
0 | 0 | 0 | 0 | 164,703 | 0 | 0 | 0 | - | - | - | - |
Payments under related party notes receivable | |||||||||||
0 | 0 | 0 | 0 | 4,344 | 0 | 0 | 0 | - | - | - | - |
Net cash provided by financing activities | |||||||||||
17,980 | 17,619 | 23,384 | 2,194 | 161,362 | 155,169 | 148,492 | 178,619 | 15,415 | 0 | 0 | 0 |
Effect of exchange rates on cash and cash equivalents and restricted cash | |||||||||||
-379 | -72 | -610 | 6 | 3 | 225 | 977 | 716 | 960 | 0 | 0 | 0 |
Net (decrease) increase in cash and cash equivalents and restricted cash | |||||||||||
-15,749 | -19,696 | -129,298 | -145,061 | 16,661 | 21,699 | 117,512 | 133,920 | -24,519 | 0 | 0 | 0 |
Supplemental disclosure of non-cash investing and financing activities: | |||||||||||
Property and equipment acquired under capital leases | |||||||||||
- | - | - | - | - | - | - | - | 644 | 0 | 0 | 0 |
Lapse in restrictions on early exercised common stock options | |||||||||||
412 | 702 | 1,257 | 1,460 | 2,088 | 2,059 | 1,582 | 1,411 | 734 | 0 | 0 | 0 |
Property and equipment purchases accrued or in accounts payable | |||||||||||
3,611 | 2,996 | 137 | 560 | 307 | 474 | 1,174 | 175 | 171 | 0 | 0 | 0 |
Deferred offering costs payable or accrued but not paid | |||||||||||
0 | 0 | -127 | -1,971 | 210 | 0 | 0 | 0 | - | - | - | - |